Searched for
ACN STOCK TODAY
For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some not- Timeless poetry of the day by Charles Bukowski: 'Some people never go crazy. What truly horrible lives they must lead...'
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 33%
- Accenture stock drops despite beating Q4 earnings estimate & strong revenue guidanceAcn stock today latest news: Accenture stock experienced a slight dip despite exceeding expectations in its fourth-quarter 2025 earnings re...26 Sep, 2025, 03.34 AM IST
- US Stock market today: Wall Street edges higher as Trump comments jolt Fed outlook, chip stocks rebound sharply after recent slumpUS Stock market today saw mixed movements as investors closely watched President Donald Trump's two-week deadline on a possible US-Iran con...20 Jun, 2025, 08.48 PM IST
- U.S. stock market futures fall: Dow, S&P 500, Nasdaq fall on oil drop, Fed signals, and rising Iran–Israel tensionsU.S. stock market futures slipped early Thursday as the Dow, S&P 500, and Nasdaq reacted to weaker oil prices, fading hopes of a Fed rate c...20 Jun, 2025, 05.22 PM IST
- Prashant Jain picks 1.1% stake in microcap firm in Q4; stock jumps 13%Star investor Prashant Jain picked up a 1.08% stake in Kaya Ltd, acquiring 1.42 lakh shares worth around Rs 3.5 crore in Q4. Kaya shares su...09 Apr, 2025, 01.35 PM IST
- Stocks in news: Sula Vineyards, Gujarat Gas, JSW Steel, ABFRL, NHPCSaudi Aramco has fixed September propane contract price at $550/tn as against current price of Rs $470/tn. In India, these prices will be a...01 Sep, 2023, 07.18 AM IST
- Nithya Balasubramanian on 2 pharma names to bet on besides Sun & Cipla“Coming to the complex generics opportunity, Cipla and Lupin are most exposed. We like Cipla more than Lupin because at least in the near t...05 Jan, 2023, 02.42 PM IST
- Stocks in the news: NMDC, Hind Copper, Indian Hotels, RITES and financialsRBI will announce its monetary policy outcome today, which is will impact rate sensitive stocks including bank, NBFCs, housing finance comp...08 Jun, 2022, 07.30 AM IST
- Stocks in the news: Jet Airways, Infibeam, Cipla and Fortis HealthcareHere are a few stocks whuich may buzz the most in today's trade.31 Dec, 2018, 09.12 AM IST
- Fourteen stocks in focus in Tuesday's tradeIndian markets are expected to trade higher. Here is a list of fourteen stocks which are likely to remain in focus today.06 Oct, 2015, 03.11 PM IST
- Sun Pharma surges after USFDA approves drug application for acne treatmentSun Pharma surged over 3% in trade today after the drug major received approval from the US health regulator for its new drug.20 Aug, 2015, 10.38 AM IST
- Lupin gets USFDA nod to market generic version of CiproLupin said it has received US health regulator USFDA'S approval to market a generic version of Bayer's Cipro, used to treat infections, in ...06 Mar, 2014, 06.46 PM IST
- Ranbaxy sets aside Rs 257.4 crore for impact of USFDA banRanbaxy Laboratories has set aside Rs 257.4 crore towards the financial impact of a US ban on import of products made at its plant at Toans...05 Feb, 2014, 06.43 PM IST
- Ranbaxy shares surge nearly 6% as Q4 net loss narrowsShares of Ranbaxy Laboratories today gained nearly 6 per cent after the company's fourth quarter net loss narrowed to Rs 158.94 crore.05 Feb, 2014, 06.05 PM IST
- Ranbaxy plunges 25% in two sessions after USFDA banShares of Ranbaxy Laboratories continued to remain under selling pressure for second straight session after the US FDA banned it from shipp...27 Jan, 2014, 11.01 AM IST
- Top ten stocks in focus on ‘muhurat’ trading dayIndian markets are likely to trade in a range with a positive bias on Wednesday. The key support level for the index is placed at 6,200 lev...03 Nov, 2013, 05.41 PM IST
- Lupin settles patent suit over Solodyn tablets with Medicis, signs R&D agreementDrug maker Lupin said it has settled patent suit with Medicis Pharmaceutical and signed a pact for development of multiple therapeutic comp...25 Jul, 2011, 05.20 PM IST
- GlaxoSmithKline buys US skincare firm Stiefel for $3.6 bnBritish drugs firm GlaxoSmithKline (GSK) said Monday it will buy Stiefel Laboratories, US maker of anti-itching creams, acne treatments and...21 Apr, 2009, 12.27 AM IST
Load More
